ZONTIVITY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aralez Pharmaceuticals Us Inc.. The primary component is Vorapaxar Sulfate.
| Product ID | 70347-208_3ae89838-2877-4ec7-a705-b0821957a1d4 |
| NDC | 70347-208 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZONTIVITY |
| Generic Name | Vorapaxar |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-05-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204886 |
| Labeler Name | Aralez Pharmaceuticals Us Inc. |
| Substance Name | VORAPAXAR SULFATE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Protease-activated Receptor-1 Antagonist [EPC],Protease-activated Receptor-1 Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-07-06 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| Marketing Category | NDA |
| Application Number | NDA204886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-01 |
| Marketing Category | NDA |
| Application Number | NDA204886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-01 |
| Marketing Category | NDA |
| Application Number | NDA204886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-07-06 |
| Ingredient | Strength |
|---|---|
| VORAPAXAR SULFATE | 2.08 mg/1 |
| SPL SET ID: | f001f406-8cf1-40a4-bbf5-1775fe020122 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66992-208 | ZONTIVITY | vorapaxar |
| 70347-208 | ZONTIVITY | vorapaxar |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZONTIVITY 86164928 not registered Dead/Abandoned |
Merck Sharp & Dohme Corp. 2014-01-14 |
![]() ZONTIVITY 85307417 4628973 Live/Registered |
ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY 2011-04-28 |